Advances in Diagnosis and Treatment of Neuroendocrine Neoplasms
To have your paper considered for this Special Collection, submit by October 31, 2023.
Please review the Manuscript Submission Guidelines before submitting your paper.
Co-Guest Editors:Dr. Rachel Riechelmann
Dr. Mairead Mcnamara
Aims & Scope:
Neuroendocrine neoplasms (NNEs) comprise a heterogenous and fascinating group of cancers that attract scientific investigation. In fact, numerous recent clinical research endeavors have been undertaken in the field of NNE, including phase III trials. However, there are still many unanswered questions in the diagnosis and therapeutic management of NNEs. This issue of Therapeutic Advances in Medical Oncology seeks studies that address new diagnostic tools and advances in the treatment of patients with NNE. The Guest Editors encourage original research submissions to join related invited review articles on topics, including but not limited to:
Please contact the Managing Editor Georgia Patey for pre-submission enquiries on firstname.lastname@example.org
Manuscript deadline: 31 October 2023
Click here to submit your paper.